StockData
Citius Pharmaceuticals, Inc. logo

Citius Pharmaceuticals, Inc. (CTXR) income statement

CTXRNasdaqPharmaceutical PreparationsFiscal year ends September 30
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 1/30
$0.51−0.01 (-1.56%)

Close on Nov 18, 2026Market cap $14.02MP/E –Yield –

Citius Pharmaceuticals, Inc. income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY

Gross margin
–
Operating margin
–
Net margin
–
Return on equity, FY2025
–

Financial strength

Current ratio
0.84
Debt to equity
4.60
Debt to assets
215.4%
Cash to current liabilities
32.9%

Valuation

P/E ratio
–
Price to sales
–
Price to book
0.21
Dividend yield
–

See a number that looks wrong?